Pharmaceutical

Filter

Current filters:

None

Popular Filters

82 to 106 of 7094 results

New Ph III data to support filing for AbbVie’s Humira in HS

13-10-2014

US pharma company AbbVie has reported new data with its mega blockbuster arthritis drug Humira (adalimumab)…

AbbVieAnti-Arthritics/RheumaticsDermatologicalsHumiraPharmaceuticalResearch

New study finds fewer drugs covered by USA’s Medicare

13-10-2014

An analysis of US government data on 2015 Medicare drug plans by HealthPocket has found that the average…

FinancialHealthcarePharmaceuticalUSA

Growth set to return to CIS by 2015 with Kazakhstan in the lead

Growth set to return to CIS by 2015 with Kazakhstan in the lead

13-10-2014

Growth is set to return to markets in the Commonwealth of Independent States between 2015 and 2019, according…

GenericsKazakhstanMarkets & MarketingPharmaceuticalRussiaUkraine

Shire awards 10,000 euros to ADHD patient groups

Shire awards 10,000 euros to ADHD patient groups

13-10-2014

Ireland-based pharma company Shire announced the winners of the 2014 Excellence in ADHD Patient Group…

Adderall XREuropeHealthcareIrelandNeurologicalPharmaceuticalShireVyvanse

FDA approves Eisai’s Akynzeo for CINV

13-10-2014

The US Food and Drug Administration has approved Japanese pharma major Eisai’s Akynzeo (netupitant…

AkynzeoEisaiHelsinnnetupitantOncologypalonosetronPharmaceuticalRegulationUSA

Novartis suspends commissioning of new Russian plant

13-10-2014

Swiss pharma major Novartis has decided to suspend the commissioning of its new Russian plant, which…

FinancialNovartisPharmaceuticalProductionRussia

Russia to start vaccines supplies to Central and South America

13-10-2014

Russia plans to start active supplies of vaccines to the Central and South America region during the…

Markets & MarketingPharmaceuticalProductionRussiaSouth AmericaVaccines

Hikma to distribute Eisai’s Fycompa in Middle East

13-10-2014

Hikma Pharmaceuticals has entered into a partnership with Japanese pharma major Eisai for the distribution…

EisaiFycompaHikma PharmaceuticalsJordanLicensingMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldSaudi Arabia

Positive Ph III results for Ipsen’s Decapeptyl in prostate cancer patients

12-10-2014

French drugmaker Ipsen has released positive results from the Phase III study of Decapeptyl (triptorelin…

DecapeptylIpsenOncologyPharmaceuticalResearch

Highlights from EMA Pharmacovigilance October meeting

10-10-2014

At its October meeting, the European Medicines Agency’ Pharmacovigilance Risk Assessment Committee…

Ariad PharmaceuticalsEuropeIclusigMen's HealthNeurologicalOncologyPharmaceuticalRegulationTestosteronevalproate

BTG settles CroFab patent litigation with Bioclon and RDT

10-10-2014

UK specialist health care company BTG says it has settled its US patent infringement complaint against…

BTGCrofabInstituto BioclonLegalPatentsPharmaceuticalRare Disease TherapeuticsRare diseasesUSA

New Zealand approval of Novartis multiproduct proposal

10-10-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

NeurologicalNew ZealandOncologyPharmaceuticalRegulationRespiratory and Pulmonary

IQWiG finds added benefit of Novartis’ Gilenya not proven

IQWiG finds added benefit of Novartis’ Gilenya not proven

10-10-2014

In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products…

GermanyGilenyaNeurologicalNovartisPharmaceuticalPricingRegulation

Oxford BioMedica enters LentiVector collaboration with Novartis

Oxford BioMedica enters LentiVector collaboration with Novartis

10-10-2014

UK-based Oxford BioMedica says that it has signed further contracts with Swiss pharma giant Novartis,…

GlobalLentiVectorLicensingMergers & AcquisitionsNovartisOncologyOxford BioMedicaPharmaceutical

Novartis' secukinumab shows strong efficacy in psoriasis Phase III trials

Novartis' secukinumab shows strong efficacy in psoriasis Phase III trials

10-10-2014

Swiss drug major Novartis has reported data from a Phase III trial showing consistent efficacy in clearing…

DermatologicalsNovartisPharmaceuticalResearchsecukinumabSwitzerland

Auxilium Pharma succumbs to higher, $2.6 billion, offer from Endo

Auxilium Pharma succumbs to higher, $2.6 billion, offer from Endo

09-10-2014

Having previously rejected a $28.10 a share takeover offer from Ireland-headquartered Endo International,…

Auxilium PharmaceuticalsEndo InternationalIrelandMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

GlaxoSmithKline takes stake in new Aspen Japanese unit

GlaxoSmithKline takes stake in new Aspen Japanese unit

09-10-2014

South African drugmaker Aspen Pharmacare says that Aspen Global Inc, a subsidiary of Aspen Holdings,…

Aspen PharmacareGlaxoSmithKlineJapanMarkets & MarketingMergers & AcquisitionsPharmaceutical

Ignorance of new treatments would leave patients worse off, says Medicines Australia

Ignorance of new treatments would leave patients worse off, says Medicines Australia

09-10-2014

A proposed campaign in Australia to stop doctors learning about new treatments from pharmaceutical companies…

AustraliaHealthcareMarkets & MarketingPharmaceutical

Cancer care is advancing, but costs cannot be ignored, says UnitedHealthcare SVP

Cancer care is advancing, but costs cannot be ignored, says UnitedHealthcare SVP

09-10-2014

Cancer care is advancing, but policymakers and the cancer care community must find ways to make it more…

HealthcareOncologyPharmaceuticalPricingUSA

82 to 106 of 7094 results

Back to top